| Name | Bitterroot Drug Inc |
|---|---|
| Organization Name | Bitterroot Drug Inc |
| Location | 211 W Main St, Hamilton, Montana 59840 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (406) 363-3611 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
New research presented today at the World Congress Summit to Improve Adherence and Enhance Patient Engagement by researchers from the University of Pittsburgh School of Pharmacy, finds that a unique generic medication sampling program, the MedVantx MedStart™ Connect program, implemented in the primary care physicians' office, led to significantly increased patient initiation of new prescriptions (primary adherence) as well as continued use of the medications (secondary adherence), and could possibly lead to savings for health plans.
In a study published online in Brain on April 1, researchers from Dr. XU Jin's lab at the Institute of Neuroscience of the Chinese Academy of Sciences and their collaborators revealed a new cellular mechanism for amyotrophic lateral sclerosis, suggested a novel therapeutic strategy targeting the RNA degradation pathway, and identified an asthma drug as a potential medication for ALS.
Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications.
A health supplement used by bodybuilders could be the key to treating a life-threatening muscular dystrophy affecting hundreds of Australian children, new research shows.
During a recent interview with The Hill's "Blog Briefing Room," Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, praised former President George W. Bush for the enactment of PEPFAR and commended the Obama administration's commitment to global health issues and for "being very open minded [and] saying we don't have to go back and reinvent the wheel."
› Verified 5 days ago
| NPI Number | 1043375975 |
| Organization Name | BITTERROOT DRUG INC |
| Doing Business As | BITTERROOT DRUG INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 211 W Main St, Hamilton, MT 59840 |
| Phone Number | 406-363-3611 |
News Archive
New research presented today at the World Congress Summit to Improve Adherence and Enhance Patient Engagement by researchers from the University of Pittsburgh School of Pharmacy, finds that a unique generic medication sampling program, the MedVantx MedStart™ Connect program, implemented in the primary care physicians' office, led to significantly increased patient initiation of new prescriptions (primary adherence) as well as continued use of the medications (secondary adherence), and could possibly lead to savings for health plans.
In a study published online in Brain on April 1, researchers from Dr. XU Jin's lab at the Institute of Neuroscience of the Chinese Academy of Sciences and their collaborators revealed a new cellular mechanism for amyotrophic lateral sclerosis, suggested a novel therapeutic strategy targeting the RNA degradation pathway, and identified an asthma drug as a potential medication for ALS.
Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications.
A health supplement used by bodybuilders could be the key to treating a life-threatening muscular dystrophy affecting hundreds of Australian children, new research shows.
During a recent interview with The Hill's "Blog Briefing Room," Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, praised former President George W. Bush for the enactment of PEPFAR and commended the Obama administration's commitment to global health issues and for "being very open minded [and] saying we don't have to go back and reinvent the wheel."
› Verified 5 days ago
News Archive
New research presented today at the World Congress Summit to Improve Adherence and Enhance Patient Engagement by researchers from the University of Pittsburgh School of Pharmacy, finds that a unique generic medication sampling program, the MedVantx MedStart™ Connect program, implemented in the primary care physicians' office, led to significantly increased patient initiation of new prescriptions (primary adherence) as well as continued use of the medications (secondary adherence), and could possibly lead to savings for health plans.
In a study published online in Brain on April 1, researchers from Dr. XU Jin's lab at the Institute of Neuroscience of the Chinese Academy of Sciences and their collaborators revealed a new cellular mechanism for amyotrophic lateral sclerosis, suggested a novel therapeutic strategy targeting the RNA degradation pathway, and identified an asthma drug as a potential medication for ALS.
Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications.
A health supplement used by bodybuilders could be the key to treating a life-threatening muscular dystrophy affecting hundreds of Australian children, new research shows.
During a recent interview with The Hill's "Blog Briefing Room," Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, praised former President George W. Bush for the enactment of PEPFAR and commended the Obama administration's commitment to global health issues and for "being very open minded [and] saying we don't have to go back and reinvent the wheel."
› Verified 5 days ago
Healthcare Providers Type: Long Term Care Pharmacy Location: 1900 North 1st Street, Hamilton, Montana 59840 Phone: (406) 363-0841 | |
Bitterroot Drug Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 211 W Main St, Hamilton, Montana 59840 Phone: (406) 363-3611 | |
Osco Pharmacy #4040 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1313 N 1st St, Hamilton, Montana 59840 Phone: (406) 363-7089 | |
Timber Ridge Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1131 N 1st St, Hamilton, Montana 59840 Phone: (406) 363-9003 | |
Norco Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1001 N 1st St, Hamilton, Montana 59840 Phone: (406) 363-1800 |